⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1025533 | 0.97 | KDM4E (0.44) | — | |
| SCHEMBL21634363 | 0.97 | KDM4E (0.44) | — | |
| SCHEMBL7533949 | 0.97 | KDM4E (0.44) | — | |
| SCHEMBL5533897 | 0.97 | KDM4E (0.44) | — | |
| SCHEMBL3879064 | 0.92 | — | — | |
| SCHEMBL3174690 | 0.86 | KDM4E (0.50) | — | |
| SCHEMBL2029681 | 0.83 | KDM4E (0.55) | — | |
| SCHEMBL5569558 | 0.83 | KDM4E (0.55) | — | |
| SCHEMBL20836564 | 0.83 | KDM4E (0.55) | — | |
| SCHEMBL30541972 | 0.83 | KDM4E (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050036976-A1 | Topical skin care composition | RUBIN JOEL (US) | 2005-02-17 | — | — | US | claimed |
| WO-2024097948-A1 | DEGRADERS OF MDM2 AND USES THEREOF | ROIVANT DISCOVERY, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20240110015-A1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SUPRAPOLIX B.V. (NL) | 2024-04-04 | — | — | US | disclosed |
| US-11884781-B2 | Supramolecular biomedical polymers | SUPRAPOLIX B.V. (NL) | 2024-01-30 | — | — | US | disclosed |
| EP-3713990-B1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SUPRAPOLIX BV (NL) | 2023-08-02 | — | — | EP | disclosed |
| CN-108546643-B | Process for large scale enzymatic synthesis of oligosaccharides | 台湾地区“中央研究院” | 2022-02-25 | — | — | CN | disclosed |
| CN-108611384-B | Process for large scale enzymatic synthesis of oligosaccharides | 台湾地区“中央研究院” | 2022-02-25 | — | — | CN | disclosed |
| CN-112955008-A | Method for preventing and treating wheat diseases, wheat seeds and method for suppressing lodging loss of wheat | 组合化学工业株式会社 | 2021-06-11 | — | — | CN | disclosed |
| EP-3713990-A1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SupraPolix B.V. (NL) | 2020-09-30 | — | — | EP | disclosed |
| US-20200277448-A1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SUPRAPOLIX B.V. (NL) | 2020-09-03 | — | — | US | disclosed |
| EP-1653961-A4 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORP (US) | 2009-04-01 | — | — | EP | disclosed |
| US-20080255143-A1 | Inhibitors of Akt Activity | SMITHKLINE BEECHAM CORPORATION (PA) | 2008-10-16 | — | — | US | disclosed |
| EP-1653961-A1 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2006-05-10 | — | — | EP | disclosed |
| US-6949577-B2 | Pharmaceuticals | PFIZER, INC. (US) | 2005-09-27 | — | — | US | disclosed |
| US-20050036976-A1 | Topical skin care composition | RUBIN JOEL (US) | 2005-02-17 | — | — | US | disclosed |
| WO-2005011700-A1 | INHIBITORS OF Akt ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2005-02-10 | — | — | WO | disclosed |
| US-20030236420-A1 | Pharmaceuticals | ALLERTON CHARLOTTE MOIRA NORFO (GB) | 2003-12-25 | — | — | US | disclosed |
| EP-1311488-A1 | SUBSTITUTED IMIDAZOLES AS TAFIA INHIBITORS | Pfizer Limited (GB) | 2003-05-21 | — | — | EP | disclosed |
| US-20020147229-A1 | Pharmaceuticals | PFIZER INC. | 2002-10-10 | — | — | US | disclosed |
| WO-2002014285-A1 | SUBSTITUTED IMIDAZOLES AS TAFIA INHIBITORS | PFIZER LIMITED (GB) | 2002-02-21 | — | — | WO | disclosed |